Ownership history in Evolutionary Tree Capital Management, LLC · 21 quarters on record
This page tracks every 13F SEC filing in which Evolutionary Tree Capital Management, LLC reported a position in ASCENDIS PHARMA A/S (ASND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 12,281 | -3,062 | -20.0% | 3.04% | $2.6M | $213.24 |
| 2025 Q3 | REDUCED | 15,343 | -3,111 | -16.9% | 3.33% | $3.1M | $198.81 |
| 2025 Q2 | REDUCED | 18,454 | -2,202 | -10.7% | 3.38% | $3.2M | $172.60 |
| 2025 Q1 | REDUCED | 20,656 | -9,459 | -31.4% | 3.74% | $3.2M | $155.86 |
| 2024 Q4 | REDUCED | 30,115 | -2,638 | -8.1% | 4.22% | $4.1M | $137.67 |
| 2024 Q3 | ADDED | 32,753 | +7,891 | +31.7% | 4.90% | $4.9M | $149.31 |
| 2024 Q2 | ADDED | 24,862 | +11,223 | +82.3% | 3.49% | $3.4M | $136.38 |
| 2024 Q1 | REDUCED | 13,639 | -3,087 | -18.5% | 2.08% | $2.1M | $151.17 |
| 2023 Q4 | ADDED | 16,726 | +69 | +0.4% | 2.33% | $2.1M | $125.95 |
| 2023 Q3 | REDUCED | 16,657 | -290 | -1.7% | 2.01% | $1.6M | $93.64 |
As of 2025 Q4 — sorted by position size